NeuroOne Medical
NMTC
NeuroOne Medical (NMTC) earnings history
Most recent quarter
- Fiscal period
- Q3 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.23
- EPS estimate
- −$0.23
- EPS surprise
- +0.00%
- Revenue surprise
- −0.40%
- Revenue
- $2.0M
- Revenue estimate
- $2.0M
- Reported
- Aug 13, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2026 | Aug 13, 2026 | −$0.23 | −$0.23 | +0.00% | $2.0M | SEC |
| Q2 2026 | May 12, 2026 | −$0.23 | −$0.25 | −10.28% | $2.4M | SEC |
| Q1 2026 | Feb 17, 2026 | −$0.18 | −$0.18 | +0.00% | $2.9M | SEC |
| Q4 2025 | Dec 17, 2025 | −$0.22 | −$0.30 | −38.12% | $2.7M | SEC |
| Q3 2025 | Aug 14, 2025 | −$0.30 | −$0.18 | +40.00% | $1.7M | SEC |
| Q2 2025 | May 13, 2025 | −$0.54 | −$0.42 | +22.22% | $1.4M | SEC |
| Q1 2025 | Jan 10, 2025 | −$0.60 | $0.36 | +160.00% | $6.3M | SEC |
| Q4 2024 | Dec 17, 2024 | −$0.54 | −$0.66 | −22.22% | $6.3M | SEC |
| Q3 2024 | Aug 14, 2024 | −$0.54 | −$0.60 | −11.11% | $825,776.00 | SEC |
| Q2 2024 | May 14, 2024 | −$0.54 | −$0.66 | −22.22% | $1.4M | SEC |
| Q1 2024 | Feb 13, 2024 | −$0.84 | −$0.84 | +0.00% | $977,649.00 | SEC |
| Q4 2023 | Dec 14, 2023 | −$1.05 | −$1.03 | +2.25% | $742,000.00 | SEC |
| Q3 2023 | Aug 14, 2023 | −$1.23 | −$1.20 | +2.44% | $629,906.00 | SEC |
| Q2 2023 | May 11, 2023 | −$1.23 | −$1.26 | −2.44% | $466,176.00 | SEC |
| Q4 2022 | Dec 22, 2022 | −$0.66 | −$0.48 | +27.27% | $2.0M | — |
| Q3 2022 | Aug 11, 2022 | −$1.35 | −$1.02 | +24.44% | $0.00 | — |
| Q2 2022 | May 12, 2022 | −$1.20 | −$1.14 | +5.00% | $18,500.00 | — |
| Q1 2022 | Feb 14, 2022 | −$1.11 | −$1.08 | +2.70% | $0.00 | SEC |
| Q4 2021 | Dec 15, 2021 | −$1.41 | −$1.08 | +23.40% | $100,000.00 | — |
| Q3 2021 | Aug 13, 2021 | $0.00 | −$1.50 | +0.00% | $100,000.00 | — |
Quarterly revenue
Frequently asked questions
When did NeuroOne Medical (NMTC) last report earnings?
NeuroOne Medical last reported on Aug 13, 2026, covering fiscal Q3 2026.
Did NMTC beat earnings estimates?
NeuroOne Medical reported EPS of −$0.23 for Q3 2026, in line with the −$0.23 consensus estimate.
How much revenue did NMTC report last quarter?
NeuroOne Medical reported $2.0M in revenue for Q3 2026, against a consensus estimate of $2.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.